Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter M Irving

Showing results (11-20 of 194) with videos related to

Pageof 20
Sort By:
Nature Reviews. Gastroenterology & Hepatology|October 6, 2011
Optimization of conventional therapy in patients with IBDKirstin M Taylor, Peter M Irving
Lancet (London, England)|April 28, 2004
Diverticular disease of the colonRichard J Makins, Peter M Irving
Expert Opinion on Biological Therapy|May 18, 2016
The impact of updated NICE guidelines on biologic treatment of ulcerative colitis: reflections on past practices, the changing present and implications for the futureMark A Samaan, Peter M Irving
Alimentary Pharmacology & Therapeutics|December 28, 2019
Editorial: establishing a joint approach to a common problem for gastroenterologistsRaphael P Luber, Peter M Irving
Journal of Gastroenterology and Hepatology|September 12, 2007
Infliximab: getting the most for your moneyPeter M Irving, Peter R Gibson
Nature Clinical Practice. Gastroenterology & Hepatology|January 5, 2008
Infections and IBDPeter M Irving, Peter R Gibson
Gastroenterology|February 15, 2022
Optimizing Therapies Using Therapeutic Drug Monitoring: Current Strategies and Future PerspectivesPeter M Irving, Krisztina B Gecse
Current Opinion in Gastroenterology|January 17, 2015
Distinct management issues with Crohn's disease of the small intestineSteven C M Fong, Peter M Irving
Alimentary Pharmacology & Therapeutics|July 8, 2021
Editorial: is tofacitinib another rescue option for acute severe ulcerative colitis?Sailish Honap, Polychronis Pavlidis, Peter M Irving
Therapeutic Advances in Gastroenterology|February 8, 2019
Golimumab in the treatment of ulcerative colitisGeorgina Cunningham, Mark A Samaan, Peter M Irving
Pageof 20

Showing results (11-20 of 194) with videos related to

Sort By:
Pageof 20
Nature Reviews. Gastroenterology & Hepatology|October 6, 2011
Optimization of conventional therapy in patients with IBDKirstin M Taylor, Peter M Irving
Lancet (London, England)|April 28, 2004
Diverticular disease of the colonRichard J Makins, Peter M Irving
Expert Opinion on Biological Therapy|May 18, 2016
The impact of updated NICE guidelines on biologic treatment of ulcerative colitis: reflections on past practices, the changing present and implications for the futureMark A Samaan, Peter M Irving
Alimentary Pharmacology & Therapeutics|December 28, 2019
Editorial: establishing a joint approach to a common problem for gastroenterologistsRaphael P Luber, Peter M Irving
Journal of Gastroenterology and Hepatology|September 12, 2007
Infliximab: getting the most for your moneyPeter M Irving, Peter R Gibson
Nature Clinical Practice. Gastroenterology & Hepatology|January 5, 2008
Infections and IBDPeter M Irving, Peter R Gibson
Gastroenterology|February 15, 2022
Optimizing Therapies Using Therapeutic Drug Monitoring: Current Strategies and Future PerspectivesPeter M Irving, Krisztina B Gecse
Current Opinion in Gastroenterology|January 17, 2015
Distinct management issues with Crohn's disease of the small intestineSteven C M Fong, Peter M Irving
Alimentary Pharmacology & Therapeutics|July 8, 2021
Editorial: is tofacitinib another rescue option for acute severe ulcerative colitis?Sailish Honap, Polychronis Pavlidis, Peter M Irving
Therapeutic Advances in Gastroenterology|February 8, 2019
Golimumab in the treatment of ulcerative colitisGeorgina Cunningham, Mark A Samaan, Peter M Irving
Pageof 20